Takuya Masui

1.1k total citations
16 papers, 241 citations indexed

About

Takuya Masui is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Takuya Masui has authored 16 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 5 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Takuya Masui's work include Electroconvulsive Therapy Studies (6 papers), Bipolar Disorder and Treatment (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Takuya Masui is often cited by papers focused on Electroconvulsive Therapy Studies (6 papers), Bipolar Disorder and Treatment (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Takuya Masui collaborates with scholars based in Japan. Takuya Masui's co-authors include Tsukasa Koyama, Ichiro Kusumi, Shin Nakagawa, Teruaki Tanaka, Katsuji Suzuki, Takeshi Inoue, Hiroshi Kunugi, Ryota Hashimoto, Yuji Kitaichi and Yasuyuki Nomura and has published in prestigious journals such as Journal of Affective Disorders, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Takuya Masui

16 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takuya Masui Japan 9 114 66 48 45 34 16 241
Keisuke Motomura Japan 8 230 2.0× 98 1.5× 69 1.4× 38 0.8× 39 1.1× 13 373
Mercedes Zumárraga Spain 12 154 1.4× 64 1.0× 40 0.8× 25 0.6× 68 2.0× 33 345
Sylvia de Jonge Germany 7 140 1.2× 117 1.8× 92 1.9× 76 1.7× 40 1.2× 8 360
Harald Krauß Germany 6 123 1.1× 72 1.1× 54 1.1× 11 0.2× 31 0.9× 9 284
Magnus Lekman Sweden 5 40 0.4× 35 0.5× 72 1.5× 49 1.1× 71 2.1× 9 297
Kerri A. Pierz United States 6 83 0.7× 112 1.7× 49 1.0× 56 1.2× 52 1.5× 9 318
Yosuke Koshikawa Japan 10 97 0.9× 37 0.6× 60 1.3× 38 0.8× 51 1.5× 25 249
WW Fleischhacker Austria 4 92 0.8× 110 1.7× 27 0.6× 71 1.6× 11 0.3× 7 321
Franz Hozer France 8 93 0.8× 28 0.4× 42 0.9× 31 0.7× 84 2.5× 14 286
Joachim Demling Germany 9 57 0.5× 44 0.7× 25 0.5× 19 0.4× 38 1.1× 23 316

Countries citing papers authored by Takuya Masui

Since Specialization
Citations

This map shows the geographic impact of Takuya Masui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Masui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Masui more than expected).

Fields of papers citing papers by Takuya Masui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Masui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Masui. The network helps show where Takuya Masui may publish in the future.

Co-authorship network of co-authors of Takuya Masui

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Masui. A scholar is included among the top collaborators of Takuya Masui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Masui. Takuya Masui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Inoue, Takeshi, Yuji Kitaichi, Takuya Masui, et al.. (2010). Pramipexole for stage 2 treatment-resistant major depression: An open study. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 34(8). 1446–1449. 29 indexed citations
2.
Nishikawa, Hiroyuki, Takeshi Inoue, Takuya Masui, et al.. (2008). Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4. Psychiatry and Clinical Neurosciences. 62(5). 591–596. 5 indexed citations
3.
Kitaichi, Yuji, Takeshi Inoue, Takeshi Izumi, et al.. (2008). Effect of co-administration of a serotonin–noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in rats. European Journal of Pharmacology. 584(2-3). 285–290. 8 indexed citations
4.
Kusumi, Ichiro, Takuya Masui, & Tsukasa Koyama. (2007). Long-term perospirone treatment with a single dose at bedtime in schizophrenia: Relevant to intermittent dopamine D2 receptor antagonism. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(2). 520–522. 6 indexed citations
5.
Nishikawa, Hiroyuki, Takeshi Inoue, Takuya Masui, Takeshi Izumi, & Tsukasa Koyama. (2007). Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31(4). 926–931. 8 indexed citations
6.
Masui, Takuya, Ryota Hashimoto, Ichiro Kusumi, et al.. (2007). A possible association between missense polymorphism of the breakpoint cluster region gene and lithium prophylaxis in bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(1). 204–208. 19 indexed citations
7.
Tanaka, Teruaki, Takeshi Inoue, Katsuji Suzuki, et al.. (2007). [Clinical relevance of antidepressant-induced activation syndrome: from a perspective of bipolar spectrum disorder].. PubMed. 109(8). 730–42. 3 indexed citations
8.
Kusumi, Ichiro, et al.. (2007). Effects of valproate on serotonin-induced intracellular calcium mobilization in human platelets. Journal of Psychiatry and Neuroscience. 32(1). 17–22. 3 indexed citations
9.
Nomura, Michio, Ichiro Kusumi, Masayuki Kaneko, et al.. (2006). Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior. Psychopharmacology. 187(1). 30–35. 59 indexed citations
10.
Masui, Takuya, Ichiro Kusumi, Yoshito Takahashi, & Tsukasa Koyama. (2006). Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 30(7). 1330–1333. 7 indexed citations
11.
Masui, Takuya, Ichiro Kusumi, Yoshito Takahashi, & Tsukasa Koyama. (2006). Effects of Itraconazole and Tandospirone on the Pharmacokinetics of Perospirone. Therapeutic Drug Monitoring. 28(1). 73–75. 8 indexed citations
12.
Inoue, Takeshi, Shin Nakagawa, Yuji Kitaichi, et al.. (2006). Long-term outcome of antidepressant-refractory depression: The relevance of unrecognized bipolarity. Journal of Affective Disorders. 95(1-3). 61–67. 27 indexed citations
13.
Kusumi, Ichiro, Takuya Masui, Chihiro Kakiuchi, et al.. (2005). Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neuroscience Letters. 391(1-2). 7–10. 12 indexed citations
14.
Masui, Takuya, Ryota Hashimoto, Ichiro Kusumi, et al.. (2005). A possible association between the [minus sign]116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder. The International Journal of Neuropsychopharmacology. 9(1). 83–83. 41 indexed citations
15.
Masui, Takuya, Ichiro Kusumi, Yoshito Takahashi, & Tsukasa Koyama. (2005). Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(2). 343–346. 4 indexed citations
16.
Masui, Takuya, et al.. (2003). [Perospirone therapy in elderly patients with schizophrenia].. PubMed. 105(10). 1247–53. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keisuke Motomura Breakdown of academic impact, for papers by Mercedes Zumárraga Breakdown of academic impact, for papers by Sylvia de Jonge Breakdown of academic impact, for papers by Harald Krauß Breakdown of academic impact, for papers by Magnus Lekman Breakdown of academic impact, for papers by Kerri A. Pierz Breakdown of academic impact, for papers by Yosuke Koshikawa Breakdown of academic impact, for papers by WW Fleischhacker Breakdown of academic impact, for papers by Franz Hozer Breakdown of academic impact, for papers by Joachim Demling
Rankless by CCL
2026